Mark James Litton Sells 25,107 Shares of Athira Pharma, Inc. (NASDAQ:ATHA) Stock
Athira Pharma, Inc. (NASDAQ:ATHA – Get Free Report) CEO Mark James Litton sold 25,107 shares of Athira Pharma stock in a transaction dated Thursday, January 2nd. The stock was sold at an average price of $0.56, for a total value of $14,059.92. Following the sale, the chief executive officer now directly owns 242,591 shares of […]
More Stories
Dimensional Fund Advisors LP Reduces Stock Holdings in SentinelOne, Inc. (NYSE:S)
Dimensional Fund Advisors LP reduced its stake in shares of SentinelOne, Inc. (NYSE:S – Free Report) by 0.0% during the...
Trump Celebrates 100 Days in Office With Michigan Auto Workers
By Emel Akan and Joseph Lord WARREN, Mich.—In a political rally on April 29 commemorating his first 100 days in...
NewEdge Advisors LLC Has $379,000 Stock Position in Enphase Energy, Inc. (NASDAQ:ENPH)
NewEdge Advisors LLC reduced its position in Enphase Energy, Inc. (NASDAQ:ENPH – Free Report) by 38.2% in the 4th quarter,...
Dimensional Fund Advisors LP Has $81.78 Million Holdings in EPAM Systems, Inc. (NYSE:EPAM)
Dimensional Fund Advisors LP boosted its holdings in shares of EPAM Systems, Inc. (NYSE:EPAM – Free Report) by 0.8% during...
QCR Holdings, Inc. (NASDAQ:QCRH) Shares Purchased by First Trust Advisors LP
First Trust Advisors LP boosted its holdings in shares of QCR Holdings, Inc. (NASDAQ:QCRH – Free Report) by 809.7% during...
NewEdge Advisors LLC Sells 2,813 Shares of DNP Select Income Fund Inc. (NYSE:DNP)
NewEdge Advisors LLC reduced its stake in shares of DNP Select Income Fund Inc. (NYSE:DNP – Free Report) by 6.6%...